UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$190M |
| 2 |
Honeywell
HON
|
+$189M |
| 3 |
Oracle
ORCL
|
+$149M |
| 4 |
JPMorgan Chase
JPM
|
+$125M |
| 5 |
Alibaba
BABA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$193M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$158M |
| 3 |
Allstate
ALL
|
+$122M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$108M |
| 5 |
General Dynamics
GD
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.94% |
| 2 | Financials | 15.35% |
| 3 | Healthcare | 13.71% |
| 4 | Consumer Discretionary | 10.59% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1901
DELISTED
Immunomedics Inc
IMMU
| $502K | ﹤0.01% |
35,911
+678
| +2% | +$6.76K |
|
1902
Compañía de Cervecerías Unidas
CCU
$2.12B
| $501K | ﹤0.01% |
18,600
| – | – |
|
1903
Innoviva
INVA
$1.55B
| $499K | ﹤0.01% |
35,341
+7,639
| +28% | +$101K |
|
|
ACOR
1904
DELISTED
Acorda Therapeutics
ACOR
| $498K | ﹤0.01% |
+176
| New | +$464K |
|
1905
Asbury Automotive
ABG
$4.31B
| $498K | ﹤0.01% |
8,157
+121
| +2% | +$6.68K |
|
1906
Orthofix Medical
OFIX
$477M
| $498K | ﹤0.01% |
10,536
+4,525
| +75% | +$213K |
|
1907
TherapeuticsMD
TXMD
$23.5M
| $497K | ﹤0.01% |
1,879
+199
| +12% | +$57.5K |
|
1908
Manitowoc
MTW
$497M
| $497K | ﹤0.01% |
13,794
+4,170
| +43% | +$121K |
|
|
DDC
1909
DELISTED
Dominion Diamond Corporation
DDC
| $496K | ﹤0.01% |
35,097
+10,400
| +42% | +$145K |
|
1910
E.W. Scripps
SSP
$257M
| $496K | ﹤0.01% |
25,945
+10,610
| +69% | +$195K |
|
1911
Heartland Express
HTLD
$948M
| $495K | ﹤0.01% |
19,725
+8,728
| +79% | +$190K |
|
1912
iShares Agency Bond ETF
AGZ
$564M
| $492K | ﹤0.01% |
4,332
-32
| -0.7% | -$3.65K |
|
|
KRA
1913
DELISTED
Kraton Corporation
KRA
| $483K | ﹤0.01% |
11,942
+5,543
| +87% | +$191K |
|
1914
Diodes
DIOD
$3.78B
| $481K | ﹤0.01% |
+16,081
| New | +$433K |
|
1915
Constellium
CSTM
$3.76B
| $479K | ﹤0.01% |
46,776
| – | – |
|
|
CRAY
1916
DELISTED
Cray, Inc.
CRAY
| $479K | ﹤0.01% |
24,649
+11,527
| +88% | +$218K |
|
|
LABL
1917
DELISTED
Multi-Color Corp
LABL
| $479K | ﹤0.01% |
+5,843
| New | +$467K |
|
1918
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
| $479K | ﹤0.01% |
16,074
-496
| -3% | -$14.7K |
|
1919
First Bancorp
FBP
$4.42B
| $478K | ﹤0.01% |
93,266
+31,090
| +50% | +$177K |
|
1920
Cavco Industries
CVCO
$4.22B
| $476K | ﹤0.01% |
3,223
| – | – |
|
1921
Invesco Senior Loan ETF
BKLN
$6.97B
| $474K | ﹤0.01% |
+20,478
| New | +$474K |
|
|
MITL
1922
DELISTED
Mitel Networks Corporation
MITL
| $472K | ﹤0.01% |
56,282
+6,602
| +13% | +$52.5K |
|
1923
Box
BOX
$4.37B
| $469K | ﹤0.01% |
24,270
+13,670
| +129% | +$257K |
|
|
AVTA
1924
DELISTED
Avantax, Inc. Common Stock
AVTA
| $468K | ﹤0.01% |
18,499
| – | – |
|
|
PDLI
1925
DELISTED
PDL BioPharma, Inc.
PDLI
| $467K | ﹤0.01% |
137,872
| – | – |
|
Similar funds
UBS AM's Q3 2017 Portfolio in Review
As of Q3 2017, UBS AM held 2,601 positions worth $110B, up 6.2% from $103B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS AM's Q3 2017 filing shows 79 new, 1,541 increased, 476 reduced and 68 closed positions. Its largest new stake was Ingersoll Rand: 2,780,577 shares worth $76.5M. The largest sale was Du Pont De Nemours E I, an estimated $193M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q3 2017 buy was Ingersoll Rand: 2,780,577 shares worth $76.5M.
- UBS AM added most to DuPont de Nemours in Q3 2017, an estimated $190M increase.
- UBS AM's biggest Q3 2017 reduction was Allstate, cutting an estimated $122M.
- UBS AM fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $193M.
- UBS AM's ten largest holdings make up 16% of its $110B portfolio in Q3 2017.
- UBS AM opened 79 new positions and closed 68 in Q3 2017.
- UBS AM's portfolio value rose 6.2% quarter-over-quarter to $110B.
Based on UBS AM's 13F filing for Q3 2017, filed 13 Nov 2017.